Integra

Integra LifeSciences Announces Leadership Transition Plan

Retrieved on: 
Wednesday, February 28, 2024
Integra, Growth, Acceleration, Heidrick & Struggles, Trust, Workforce, Management

PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (“Integra” or “the Company”) (NASDAQ: IART), a leading global medical technology company, today announced that Jan De Witte has informed the Board of Directors (the “Board”) of his intention to retire from his position as president and chief executive officer of Integra following the appointment of a successor, which the Company expects to occur by the end of 2024. The Company also announced that Stuart Essig, Integra’s chairman, has been appointed to the role of executive chairman, effective immediately.

Key Points: 
  • “We are grateful to Jan for his leadership and commitment to Integra and the role he has played in advancing our portfolio and building upon our legacy of innovation,” said Stuart Essig, chairman of the Board.
  • “Jan’s personal decision to retire from Integra and return to Europe follows a leadership tenure marked by significant contributions to the company, including the evolution of our strategy and an expansion of core capabilities.
  • Mr. De Witte said, “I am incredibly proud of everything we have accomplished together here at Integra.
  • Mr. De Witte will address the leadership transition during Integra’s fourth quarter and full-year 2023 financial results conference call, which is scheduled for later today at 8:30 a.m.

2024 Canadian Car of the Year winners announced by Automobile Journalists Association of Canada

Retrieved on: 
Thursday, February 15, 2024
Toyota, International Auto Show, Genesis G80, Integra, SUV, Toyota Prius, Acura, Sale, Type S, Hyundai Ioniq 5, Accord, Toyota Highlander, Genesis, Utility vehicle, G80, Kia, Hyundai, Automotive industry

TORONTO, Feb. 15, 2024 /CNW/ - The four winners of the 2024 Canadian Car of the Year Awards (CCOTY), presented by the Automobile Journalists Association of Canada (AJAC), were announced today during the opening ceremonies of the Canadian International Auto Show.

Key Points: 
  • TORONTO, Feb. 15, 2024 /CNW/ - The four winners of the 2024 Canadian Car of the Year Awards (CCOTY), presented by the Automobile Journalists Association of Canada (AJAC), were announced today during the opening ceremonies of the Canadian International Auto Show.
  • The Toyota Prius is the 2024 Canadian Car of the Year.
  • The 2024 Canadian Utility Vehicle of the Year is the Toyota Grand Highlander.
  • The Genesis Electrified G80 takes home the award as the 2024 Canadian Electric Car of the Year.

INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Investors to Contact the Firm

Retrieved on: 
Wednesday, February 14, 2024
Complaint, Acquisition, Integra, Boston, FDA, Lipopolysaccharide, Management control system, Pharmaceutical industry

PHILADELPHIA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it has commenced an investigation into Integra LifeSciences Holdings Corp. (NASDAQ: IART) (“Integra”) on behalf of the company’s long-term investors.

Key Points: 
  • PHILADELPHIA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it has commenced an investigation into Integra LifeSciences Holdings Corp. (NASDAQ: IART) (“Integra”) on behalf of the company’s long-term investors.
  • After receiving the 2018 Form 483, Integra issued a series of responses purporting to address the problems identified by the FDA.
  • Integra shareholders who purchased or acquired their shares prior to April 26, 2023 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.
  • Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation.

Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024

Retrieved on: 
Wednesday, February 7, 2024
Integra

PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, prior to the market open.

Key Points: 
  • PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, prior to the market open.
  • In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m.
  • For those planning to participate on the call, register here to receive dial-in details and an individual pin.
  • A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

Cylera and Integra e-Quip Forge Alliance to Enhance Healthcare Cyber Defence and IoT Asset Management

Retrieved on: 
Tuesday, January 23, 2024
Classification, Patient, HPH, Internet, Health care, CMMS, Partnership, Intelligence, Trust, Integra, Public, IoMT, Safety, Internet of things, Pharmaceutical industry

Users of e-Quip with Cylera can now gain automated discovery, classification, and inventory management for all their connected IoMT assets.

Key Points: 
  • Users of e-Quip with Cylera can now gain automated discovery, classification, and inventory management for all their connected IoMT assets.
  • Together, we're transforming the approach to IoT security in the field of healthcare, making proactive defence possible."
  • Our collaboration with Cylera underscores our dedication to supplying top-tier solutions for device management, vendor monitoring, and preventative maintenance.
  • By incorporating IoT security from Cylera into our services, we are empowering our customers to reach unprecedented heights in operational performance and protection."

WOUND CARE LEADER, GENTELL, EXPANDS ITS GLOBAL FOOTPRINT ADDING KEY EXECUTIVE LEADERSHIP IN THE UK, EUROPE AND BRAZIL

Retrieved on: 
Monday, January 15, 2024
Hospice, Integra LifeSciences, National Health Service, Patient, Hospital, Foot, Intelligence, AI, Integra, Data collection, Controller, NHS, Management

The new executives include:

Key Points: 
  • The new executives include:
    Our vision: a new paradigm for wound care, using technology, data collection & AI to improve upon delivery & recovery.
  • Singh has been a top executive in the U.K.'s National Health Service (NHS) for nearly 20 years, in both regulation and provider land.
  • Mr. Singh will now lead Gentell U.K. and Europe in its efforts to improve and support patient -specific delivery of affordable wound care treatments.
  • Gentell will manufacture advanced wound care products and dressings at these facilities, as well as in its plant in Pennsylvania.

Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Friday, January 5, 2024
Integra

PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 42nd Annual J.P. Morgan Healthcare conference on January 10, 2024 at 1:30pm ET.

Key Points: 
  • PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 42nd Annual J.P. Morgan Healthcare conference on January 10, 2024 at 1:30pm ET.

Oasis Marinas Expands Management Portfolio with Sunset Bay Marina, Located Along Florida's Renowned Treasure Coast

Retrieved on: 
Wednesday, January 3, 2024
Okeechobee Waterway, Sunlight, Heart, Return, Integra, Coffee, Casino

BALTIMORE, Jan. 3, 2024 /PRNewswire-PRWeb/ -- Today, Oasis Marinas, one of the nation's leading marina hospitality and management partners, announces the expansion of its management portfolio with the addition of a prestigious marina, Sunset Bay Marina. The addition of Sunset Bay Marina reaffirms the company's commitment to expanding its presence in key boating destinations and ensuring the highest standards of quality for boaters.

Key Points: 
  • Sunset Bay Marina, with its idyllic setting along Florida's Treasure Coast, aligns seamlessly with this vision," said Kenneth Svendsen, chief executive officer of Oasis Marinas.
  • Sunset Bay Marina, with its idyllic setting along Florida's Treasure Coast, aligns seamlessly with this vision," said Kenneth Svendsen, chief executive officer of Oasis Marinas.
  • Sunset Bay Marina marks the seventh property managed by Oasis Marinas.
  • "Our companies share a commitment in our dedication to excellence, and we look forward to delivering that to Sunset Bay."

InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America

Retrieved on: 
Wednesday, January 3, 2024
NSPR, NuVasive, TEL, Stroke, Integra, IDE, Globus Medical, Integra LifeSciences, Orthopedic surgery, Growth, Rutgers University, Patient, Compensated emancipation, Stenosis, Employment, Syracuse University, NSO, EPS, Senior

TEL AVIV, Israel and MIAMI, Jan. 03, 2024 (GLOBE NEWSWIRE) -- InspireMD (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, announced today the appointment of medical technology executive Pete Ligotti as Executive Vice President and General Manager of North America. Mr. Ligotti brings more than 30 years of general management and commercial leadership experience to the InspireMD team.

Key Points: 
  • TEL AVIV, Israel and MIAMI, Jan. 03, 2024 (GLOBE NEWSWIRE) -- InspireMD (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, announced today the appointment of medical technology executive Pete Ligotti as Executive Vice President and General Manager of North America.
  • Mr. Ligotti brings more than 30 years of general management and commercial leadership experience to the InspireMD team.
  • Before that, he served as Vice President of Global Commercial Strategy at Smith+Nephew, and, prior to that, in various roles of increasing responsibility at Integra LifeSciences, culminating with Senior Vice President and General Manager - Extremity Orthopedics.
  • In connection with the appointment of Mr. Ligotti as Executive Vice President and General Manager of North America, InspireMD has granted Mr. Ligotti 138,460 shares of restricted stock and stock options to purchase 46,150 shares of InspireMD’s common stock.

Integra Submits Draft Mine Plan of Operations for the DeLamar Project

Retrieved on: 
Wednesday, December 20, 2023
Biophysical environment, SME, Metallurgy, BLM, EDGAR, Consultant, Sustainability, Retirement, DEIS, Exploration, News, Barrick Gold, Integra, Kinross Gold, Social, University, Equity, MPO, Growth, Engineer, PEA, Bald Mountain mine, Technical report, PFS, Corps, NEPA, Management

These studies will also be used to further develop the reclamation and closure plan at DeLamar.

Key Points: 
  • These studies will also be used to further develop the reclamation and closure plan at DeLamar.
  • Upon receipt of a completeness determination from the BLM, Integra will begin the Notice of Intent process which initiates development of the DEIS in mid-2024.
  • Integra recently published the latest Sustainability Report for DeLamar which outlines the Company's commitments and performance in its Environmental, Social and Governance practices.
  • The past producing DeLamar project, which includes the adjacent DeLamar and Florida Mountain gold and silver deposits, is located in Owyhee County in southwest Idaho.